Ceretas LtdASX: CTS

Milestone 3 Completed for CUREator Program

Sep 15, 2026 at 7:41 PM EDT · Issued by Ceretas Ltd via ASX

Filed with ASX · Sep 15, 2026 at 7:41 PM EDT

On 6ix: 6ix.com/news/milestone-3-completed-for-cureator-program

Ceretas Limited (ABN 15 681 662 224) Level 4 348 Edward St Brisbane QLD 4000 Australia +61 7 3543 4424 | [email protected] | www.ceretas.com.au ASX Announcement Milestone 3 completed to advance CUREator+ Dementia & Cognitive Decline Program Funding § Milestone 3 of CUREator+ Dementia & ...

View Attachment

6ix hasn’t read this filing yet.

Ceretas Ltd on 6ix

Earlier from Ceretas

Ethics Committee Approval Secured for Additional Trial SitesAug 30
Appendix 4GAug 30
Corporate Governance StatementAug 30
Appendix 4E & Annual Report 30 June 2026Aug 30
Change of AddressAug 14

Later from Ceretas

Date of AGM and Closing Date for Director NominationsSep 22
Investor Presentation - October 2026Oct 18
Notice of Annual General Meeting/Proxy FormOct 21
First Patient Enrolled in Phase 2 CERE-CALM Clinical TrialOct 28
Quarterly Activities/Appendix 4C Cash Flow ReportOct 29

All Ceretas news releases

Follow Ceretas into a list and get an email when it puts out news.

Follow Ceretas